Amneal Pharmaceuticals (AMRX) Acquires 98% Interest in Kashiv Specialty Pharmaceuticals Jan 12, 2021 06:07AM
Amneal to Acquire Substantially All of Kashiv Specialty Pharmaceuticals Jan 12, 2021 06:00AM
Pre-Open Stock Movers 07/10: (WIMI) (MATX) (SPAQ) Higher; (ZIOP) (FC) (WDFC) Lower (more...) Jul 10, 2020 09:26AM
Amneal Pharmaceuticals (AMRX) PT Raised to $4 at RBC Capital Jan 2, 2020 06:17AM
Amneal Pharmaceuticals (AMRX) to Acquire Majority Interest in AvKARE Dec 10, 2019 07:04AM


Dec 10, 2019 06:59AM Amneal to Acquire Majority Interest in AvKARE, Enhancing Access to Growing Federal Healthcare Market
Aug 6, 2019 06:35AM Amneal Pharmaceuticals (AMRX) PT Lowered to $5 at RBC Capital
Jul 11, 2019 01:44AM RBC Capital Downgrades Amneal Pharmaceuticals (AMRX) to Sector Perform
May 15, 2019 09:25AM Amneal Pharmaceuticals to Present at the RBC Capital Markets Global Healthcare Conference
May 10, 2019 06:47AM Amneal Pharmaceuticals (AMRX) PT Lowered to $17 at RBC Capital
Feb 26, 2019 06:27AM Amneal Pharmaceuticals (AMRX) PT Lowered to $23 at RBC Capital
Dec 31, 2018 06:43AM Amneal Pharmaceuticals (AMRX) Top Generic Idea for 2019 - RBC
Aug 13, 2018 07:12AM UPDATE: RBC Capital Upgrades Amneal Pharmaceuticals (AMRX) to Outperform; EBITDA Ramp is Beginning
Jun 5, 2018 04:15PM Impax Laboratories, LLC Announces Results of Tender Offer for 2.00% Convertible Senior Notes Due 2022